FDA Determines Regulatory Review Period for SUPERA PERIPHERAL STENT SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the SUPERA PERIPHERAL STENT SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).